The administration of mAbs directed against CD25 as ‘surrogate’ Treg cell marker largely preserves systemic immune homeostasis and has been employed to examine the role of Foxp3+ Treg cells in the control of β cell autoimmunity. This evidence concerns the gene FOXP3 and Autoimmunity.